That seems to sum up medical advancement i guess. It works both ways as the FDA or whoever make it so expensive to get a drug to market, though at the same time we absolutely need to be sure of safety. Medical costs are just spiralling though. Pyc could quite possibly have developed imyc as a great cancer treatment but it got dropped pretty much for financial reasons it seems. Sad world. But at least pyc is rising and apparently holding for the first time in a decade.
Ann: Successful Competitive Drug Evaluation in Animals, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |